These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9623556)

  • 1. A 3-year follow-up of HCV-RNA viraemia in haemodialysis patients.
    Galán F; Pérez-Gracia MT; Lozano A; Benavides B; Fernandez-Ruíz E; Rodríguez-Iglesias MA
    Nephrol Dial Transplant; 1998 May; 13(5):1211-4. PubMed ID: 9623556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of viraemia in haemodialysis patients with hepatitis C.
    Dzekova-Vidimliski P; Asani A; Selim G; Gelev S; Polenakovic M; Sikole A
    Prilozi; 2008 Dec; 29(2):201-11. PubMed ID: 19259047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?
    Papadopoulos N; Griveas I; Sveroni E; Argiana V; Kalliaropoulos A; Martinez-Gonzalez B; Deutsch M
    Int J Artif Organs; 2018 Mar; 41(3):168-170. PubMed ID: 29546809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients.
    Fabrizi F; Lunghi G; Marai P; Marcelli D; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1996 Jan; 11(1):159-64. PubMed ID: 8649626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus genotypes in chronic dialysis patients.
    Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1996 Apr; 11(4):679-83. PubMed ID: 8671858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus antibodies, viral RNA and genotypes in sera from patients on maintenance haemodialysis.
    Masuko K; Okuda K; Meguro T; Murayama N; Mitsui T; Ohmori T; Murata K; Tsuda F; Okamoto H
    J Viral Hepat; 1994; 1(1):65-71. PubMed ID: 8790561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV-RNA Pcr Positivity In Hcv Antibody Negative Patients Undergoing Haemodialysis.
    Kiani IG; Khan AN; Butt B; Sabir S; Ejaz S; Perveen A; Ghani E
    J Ayub Med Coll Abbottabad; 2018; 30(3):397-400. PubMed ID: 30465373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of HCV viraemia in anti-HCV-negative haemodialysis patients.
    Dalekos GN; Boumba DS; Katopodis K; Zervou E; Sferopoulos G; Elisaf M; Tsianos EV; Siamopoulos KC
    Nephrol Dial Transplant; 1998 Jul; 13(7):1804-6. PubMed ID: 9681732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection.
    Furusyo N; Hayashi J; Ariyama I; Sawayama Y; Etoh Y; Shigematsu M; Kashiwagi S
    Am J Gastroenterol; 2000 Feb; 95(2):490-6. PubMed ID: 10685756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate.
    de Oliveira JM; Rispeter K; Viazov S; Saback FL; Roggendorf M; Yoshida CF
    J Med Virol; 2001 Apr; 63(4):265-70. PubMed ID: 11241456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
    Mederacke I; Meier M; Lüth JB; Schmidt-Gürtler H; Raupach R; Horn-Wichmann R; Wursthorn K; Potthoff A; Colucci G; Manns MP; Wedemeyer H; Tillmann HL
    Nephrol Dial Transplant; 2011 Aug; 26(8):2648-56. PubMed ID: 21273235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
    Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
    Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype distribution and transmission of hepatitis C virus (HCV) in French haemodialysed patients.
    Bouchardeau F; Chauveau P; Courouce AM; Poignet JL
    Nephrol Dial Transplant; 1995 Dec; 10(12):2250-2. PubMed ID: 8808220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening.
    Irish DN; Blake C; Christophers J; Craske JE; Burnapp L; Abbs IC; MacMahon EM; Muir P; Banatvala JE; Simmonds P
    J Med Virol; 1999 Oct; 59(2):135-40. PubMed ID: 10459146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of hepatitis C virus infection in dialysis patients.
    Fabrizi F; Lunghi G; Pagliari B; Mangano S; Faranna P; Pagano A; Locatelli F
    Nephron; 1997; 77(2):190-6. PubMed ID: 9346386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.